SCHEMBL4629317

SCHEMBL4629317

NC(N)=Nc1cnc2ccccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 4/20 0.55
HTR3B O95264 4/20 0.55
HTR3A P46098 4/20 0.55
HTR3D Q70Z44 4/20 0.55
HTR3C Q8WXA8 4/20 0.55
CYP1A2 P05177 2/20 0.52
PLAU P00749 3/20 0.50
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
ALDH1A1 P00352 2/20 0.49
PRKAG1 P54619 1/20 0.49
PRKAA1 Q13131 1/20 0.49
PRKAB1 Q9Y478 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ADRA2A P08913 6/20 0.49
ADRA2B P18089 6/20 0.49
ADRA2C P18825 6/20 0.49
MGAM O43451 1/20 0.46
CYP2D6 P10635 1/20 0.46
MPI P34949 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18543952 0.78 CYP1A2 (0.51) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL18543955 0.78 CYP1A2 (0.51) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL18543993 0.76 CYP1A2 (0.49) HTR3ACYP1A2HPGDHSD17B10ALDH1A1
SCHEMBL128094 0.76 ALDH1A1 (0.57) HTR3ACYP1A2HPGDHSD17B10ALDH1A1
SCHEMBL3684655 0.76 ALDH1A1 (0.57) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL10156228 0.76 ALDH1A1 (0.53) HTR3ACYP1A2HPGDHSD17B10ALDH1A1
SCHEMBL21192695 0.73 CYP1A2 (0.46) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL21192693 0.73 CYP1A2 (0.46) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL5658262 0.71 ALDH1A1 (0.49) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1
SCHEMBL7119499 0.71 ALDH1A1 (0.49) CYP1A2HPGDHSD17B10ALDH1A1PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917244-A2 HETARYL-SUBSTITUTED GUANIDINE COMPOUNDS AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5-RECEPTORS Abbott GmbH & Co. KG (DE) 2008-05-07 EP disclosed
WO-2007022964-A2 HETARYL-SUBSTITUTED GUANIDINE COMPOUNDS AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5-RECEPTORS ABBOTT GMBH & CO. KG (DE) 2007-03-01 WO disclosed